Safety Study of Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Samsung Medical Center
Information provided by (Responsible Party):
Jennerex Biotherapeutics
ClinicalTrials.gov Identifier:
NCT01380600
First received: June 22, 2011
Last updated: January 13, 2014
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2014
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)